Tag: Veterinary drugs

Bayer’s Effective Flea Control for Pets Registered in China

The brand is now available in China with its enormous increase in pet ownership and growth of urban populations. Bayer Animal Health launched Advantage™ during the 11th East and West Small-Animal V...

Fundamental GMP Deficiencies of Homeopathic Drugs Manufacturer

Due to fundamental GMP deficiencies, the FDA has issued a Warning letter to a US manufacturer of homeopathic drugs for human and veterinary use. As one such deficiency, the FDA listed a missing CAP...

Bayer and adivo to Develop Therapeutic Antibodies for Vet Med

Bayer Animal Health GmbH and adivo GmbH have signed a global collaboration agreement to develop therapeutic antibodies for veterinary medicine. Under the terms of the agreement, Bayer Animal Health wi...

European Committee for Medicinal Products for Veterinary Use Meeting Took Place

veterinary drug
The Committee adopted by consensus a positive opinion for a grouped type II variation application for Suvaxyn PRRS MLV to reduce the onset of immunity and implement changes to the product information....

EMA Recommended Marketing of Bayer’s Suspension for Piglets

The Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency has, by consensus, adopted a positive opinion recommending marketing authorisation for the veterinary me...

Boehringer Ingelheim and GNA Partner to Fight ASF

Boehringer Ingelheim and GNA Biosolutions announce that they have entered into a research collaboration focused on the development of a rapid African swine fever (ASF) diagnostic test. The test would ...

Results of Inspection of Veterinary Products for the GMP Compliance

Inspection activities aimed at confirming the compliance of a manufacturer of veterinary medicinal products with the requirements of Good Manufacturing Practice (GMP) are carried out by the Federal Se...

Sales of veterinary antimicrobials in Europe decreased by about 20%

A new report published by European Medicines Agency (EMA) shows that the overall sales of veterinary antimicrobials across Europe have decreased by more than 20% between 2011 and 2016.

Cuban veterinary vaccine broadens its market

In the last eight years the Cuban vaccine against cattle tick developed by the Center for Genetic Engineering and Biotechnology has produced incomes for more than 20 million dollars to the country.

Boehringer Ingelheim to invest €200 million into a new veterinary facility

boehringer ingelheim
The company will establish the new site in the French Rhône-Alpes region, which is known as the European “vaccine valley”. The completed building expected to be operational at the end of 2021.

EMA recommended marketing authorization for the first stem cell veterinary drug

veterinary drug
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Veterinary Use (CVMP) has recommended a marketing authorization for the first veterinary stem cell-based medicine in the European Union (EU).

Uzbek manufacturers of veterinary drugs may receive preferential treatment

Uzbekistan wants to provide preferences to local enterprises manufacturing veterinary drugs, according to a draft decree of the local government.

Imports of veterinary APIs to Russia declined by 2% in January 2018

veterinary vaccine
January 2018 was marked by extremely uneven trends in supplies of veterinary products. Over the year, the supply of feed additives decreased by 13%, while the imports of veterinary drugs showed small, but positive growth.

Dechra Pharmaceuticals buys two European pharma companies

veterinary drug
Dechra Pharmaceuticals, a UK veterinary company, announced the acquisition of two European pharmaceutical business as well as a share placing to part-fund the purchases

GreenBioVet will establish veterinary drugs production in Minsk SEZ

pharmaceutical manufacturing
In early January 2018, Minsk Special Economic Zone registered GreenBioVet as new resident to implement an investment project on building a plant for manufacturing veterinary disinfectants and antiseptics

Veterinary drugs manufacturers in EAEU are exempted from additional control

The Board of the EEC decided that the companies of EAEU countries involved in the manufacturing and storage of medicines for animals should not be included in the Union’s Register